Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Astrazeneca Pharmaceuticals recalls Fasenra (benralizumab) Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility:
Products
  • Fasenra (benralizumab) Injection
Company
Astrazeneca Pharmaceuticals
Where it was sold

Nationwide in the U.S

Nationwide

Units affected
916 pre-filled syringes
About this recall
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30